Novel substituted pyrimidines as HCV replication (replicase) inhibitors.

@article{Kwong2012NovelSP,
  title={Novel substituted pyrimidines as HCV replication (replicase) inhibitors.},
  author={Cecil D. Kwong and Jeremy L Clark and Anita T Fowler and Feng Geng and Hollis S Kezar and Abhijit Roychowdhury and Robert C. Reynolds and Joseph A. Maddry and Subramaniam Ananthan and John A. Secrist and Neng-Yang Shih and John J. Piwinski and Cheng Li and Boris Feld and Hsueh-Cheng Huang and Xiao Mei Tong and F George Njoroge and Ashok Arasappan},
  journal={Bioorganic & medicinal chemistry letters},
  year={2012},
  volume={22 2},
  pages={1160-4}
}
Compound 1 was identified as a HCV replication inhibitor from screening/early SAR triage. Potency improvement was achieved via modulation of substituent on the 5-azo linkage. Due to potential toxicological concern, the 5-azo linkage was replaced with 5-alkenyl or 5-alkynyl moiety. Analogs containing the 5-alkynyl linkage were found to be potent inhibitors of HCV replication. Further evaluation identified compounds 53 and 63 with good overall profile, in terms of replicon potency, selectivity… CONTINUE READING

From This Paper

Topics from this paper.
1 Citations
0 References
Similar Papers

Citations

Publications citing this paper.

Similar Papers

Loading similar papers…